|
| | Androst-3-en-17-one,(5) Basic information |
| Product Name: | Androst-3-en-17-one,(5) | | Synonyms: | 10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,16-dodecahydrocyclopenta[a]phenanthren-17-one;5a-Androst-3-en-17-one;5α-Androst-3-en-17-one;Androst-3-en-17-one,(5);Rocuronium Impurity 16;(5S,8R,9S,10S,13S,14S)-10,13-dimethyl;(5S,8R,9S,10S,13S,14S)-10,13-dimethyl-1,2,5,6,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one;Rocuronium Bromide Impurity 2 | | CAS: | 14935-81-0 | | MF: | C19H28O | | MW: | 272.42 | | EINECS: | | | Product Categories: | | | Mol File: | 14935-81-0.mol |  |
| | Androst-3-en-17-one,(5) Chemical Properties |
| Melting point | 125-126 °C(Solv: hexane (110-54-3)) | | Boiling point | 371.6±42.0 °C(Predicted) | | density | 1.032±0.06 g/cm3(Predicted) | | solubility | Chloroform (Slightly), Dichloromethane (Slightly) | | form | Solid | | color | White to Off-White |
| | Androst-3-en-17-one,(5) Usage And Synthesis |
| Uses | (5α)-Androst-3-en-17-one is a new potent steroidal aromatase inhibitor. Aromatase inhibitors are a class of drugs used in the treatment of breast cancer in postmenopausal women and gynecomastia in men | | Definition | ChEBI: (5alpha)-androst-3-en-17-one is an androstanoid that is (5alpha)-androst-3-ene substituted by an oxo group at position 5. It has a role as a human metabolite. It is a 17-oxo steroid and an androstanoid. |
| | Androst-3-en-17-one,(5) Preparation Products And Raw materials |
|
